Login / Signup

Safety of Gadolinium-Based Contrast Agents in Patients with Stage 4 and 5 Chronic Kidney Disease: a Radiologist's Perspective.

Erik V SoloffCarolyn L Wang
Published in: Kidney360 (2020)
Keyphrases
  • chronic kidney disease
  • end stage renal disease
  • contrast enhanced
  • magnetic resonance
  • magnetic resonance imaging
  • peritoneal dialysis
  • computed tomography